Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study

Thromb Res. 2024 Apr:236:127-129. doi: 10.1016/j.thromres.2024.02.027. Epub 2024 Feb 27.

Authors

Connor Flynn¹, Julie Baldassarra², Arzo Hamidi³

Affiliations

¹ Department of Pharmacy, Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612, USA. Electronic address: conjflynn@gmail.com.
² Department of Pharmacy, Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612, USA. Electronic address: julie_baldassara@rush.edu.
³ Department of Pharmacy, Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612, USA. Electronic address: arzo_hamidi@rush.edu.

PMID: 38430903
DOI: 10.1016/j.thromres.2024.02.027

No abstract available

Keywords: Acute kidney injury; Anticoagulant; Continuous renal replacement therapy; Critical illness; Venous thromboembolism.

Publication types

Letter

MeSH terms

Anticoagulants / adverse effects
Enoxaparin / adverse effects
Humans
Kidney Diseases*
Retrospective Studies
Venous Thromboembolism* / drug therapy
Venous Thrombosis*

Substances

Enoxaparin
Anticoagulants